FFCP PHASE1:Mm9::chr12:26004849..26004857,-: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|EntrezGene=NA|HGNC=|MCL_coexpression_id=3|UniProt=NA|association_with_transcript=NA|description=CAGE_peak_at_chr12:26004849..26004857,-|id=chr12:26004849..26004857,-|ontology_enrichment_celltype=|ontology_enrichment_celltype_v019_2=CL:0000355,3.30e-15,9|ontology_enrichment_disease=DOID:0060100!2.61e-13!3;DOID:4045!2.61e-13!3;DOID:0050686!7.33e-07!6|ontology_enrichment_disease_v019_2=DOID:0060100,8.97e-44,3;DOID:4045,8.97e-44,3;DOID:0050686,2.23e-22,6|ontology_enrichment_uberon=|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.30e-15,9;UBERON:0002036,3.30e-15,9;UBERON:0002385,3.30e-15,9;UBERON:0000486,3.30e-15,9;UBERON:0007503,3.30e-15,9;UBERON:0001015,3.30e-15,9;UBERON:0002329,3.30e-15,9;UBERON:0003082,3.30e-15,9;UBERON:0003059,3.30e-15,9;UBERON:0007282,3.30e-15,9;UBERON:0004290,3.30e-15,9;UBERON:0009618,3.30e-15,9;UBERON:0000383,9.08e-14,10;UBERON:0007524,1.37e-12,11;UBERON:0003077,1.37e-12,11;UBERON:0007285,1.37e-12,11|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.137114433605739,0,0,0.198581902401771,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.4632907684227,8.5946887897618,12.0410461113974,19.4116391050235,8.19654581950135,17.4783727091215,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,0,0,0,0,0.220841518460394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232236671860439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0,0.25462585178142,0.575392274901621,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206386867963223,0.370389054739423,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.375364950902364,0.183151624267265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206035057238894,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0|short_description=p@chr12:26004849..26004857,-}} | {{FFCP | ||
|DHSsupport=NA | |||
|DPIdataset=NA | |||
|EntrezGene=NA | |||
|HGNC= | |||
|MCL_coexpression_id=3 | |||
|TSSclassifier=NA | |||
|UniProt=NA | |||
|association_with_transcript=NA | |||
|cluster_id=chr12:26004849..26004857,- | |||
|description=CAGE_peak_at_chr12:26004849..26004857,- | |||
|id=chr12:26004849..26004857,- | |||
|ontology_enrichment_celltype= | |||
|ontology_enrichment_celltype_v019_2=CL:0000355,3.30e-15,9 | |||
|ontology_enrichment_disease=DOID:0060100!2.61e-13!3;DOID:4045!2.61e-13!3;DOID:0050686!7.33e-07!6 | |||
|ontology_enrichment_disease_v019_2=DOID:0060100,8.97e-44,3;DOID:4045,8.97e-44,3;DOID:0050686,2.23e-22,6 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019_2=UBERON:0001134,3.30e-15,9;UBERON:0002036,3.30e-15,9;UBERON:0002385,3.30e-15,9;UBERON:0000486,3.30e-15,9;UBERON:0007503,3.30e-15,9;UBERON:0001015,3.30e-15,9;UBERON:0002329,3.30e-15,9;UBERON:0003082,3.30e-15,9;UBERON:0003059,3.30e-15,9;UBERON:0007282,3.30e-15,9;UBERON:0004290,3.30e-15,9;UBERON:0009618,3.30e-15,9;UBERON:0000383,9.08e-14,10;UBERON:0007524,1.37e-12,11;UBERON:0003077,1.37e-12,11;UBERON:0007285,1.37e-12,11 | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.137114433605739,0,0,0.198581902401771,0.261199789138935,0,0,0,0,0,0,0,0,0,0,0,0,0,0,10.4632907684227,8.5946887897618,12.0410461113974,19.4116391050235,8.19654581950135,17.4783727091215,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.173485326766136,0,0,0,0,0,0,0,0,0,0.220841518460394,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.248813941220186,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.232236671860439,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.202860121388503,0,0.25462585178142,0.575392274901621,0.162135226775035,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206386867963223,0.370389054739423,0,0,0,0,0,0.138199973804424,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.375364950902364,0.183151624267265,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.206035057238894,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p@chr12:26004849..26004857,- | |||
}} |
Latest revision as of 22:18, 4 August 2015
Short description: | p@chr12:26004849..26004857, - |
---|---|
Species: | Mouse (Mus musculus) |
DPI dataset: | NA |
TSS-like-by-RIKEN-classifier(Yes/No): | NA |
DHS support(Yes/No): | NA |
Description: | CAGE_peak_at_chr12:26004849..26004857, - |
Coexpression cluster: | MCL_coexpression_mm9:3 |
Association with transcript: | NA |
EntrezGene: | NA |
Link to Zenbu: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
multi-potent skeletal muscle stem cell | 3.30e-15 | 9 |
Ontology term | p-value | n |
---|---|---|
skeletal muscle tissue | 3.30e-15 | 9 |
striated muscle tissue | 3.30e-15 | 9 |
muscle tissue | 3.30e-15 | 9 |
multilaminar epithelium | 3.30e-15 | 9 |
epithelial vesicle | 3.30e-15 | 9 |
musculature | 3.30e-15 | 9 |
somite | 3.30e-15 | 9 |
myotome | 3.30e-15 | 9 |
presomitic mesoderm | 3.30e-15 | 9 |
presumptive segmental plate | 3.30e-15 | 9 |
dermomyotome | 3.30e-15 | 9 |
trunk paraxial mesoderm | 3.30e-15 | 9 |
musculature of body | 9.08e-14 | 10 |
dense mesenchyme tissue | 1.37e-12 | 11 |
paraxial mesoderm | 1.37e-12 | 11 |
presumptive paraxial mesoderm | 1.37e-12 | 11 |
Ontology term | p-value | n |
---|---|---|
musculoskeletal system cancer | 8.97e-44 | 3 |
muscle cancer | 8.97e-44 | 3 |
organ system cancer | 2.23e-22 | 6 |